EyePoint, Inc. Interest Expense Nonoperating
EyePoint, Inc. (EYPT) reported Interest Expense Nonoperating of $33.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Expense Statement
us-gaap:InterestExpenseNonoperating · last filed 2026-03-05
- EyePoint, Inc. interest expense nonoperating for fiscal 2025 was $33.00K, a 135.71% increase from fiscal 2024.
- EyePoint, Inc. interest expense nonoperating for fiscal 2024 was $14.00K, a 98.88% decline from fiscal 2023.
- EyePoint, Inc. interest expense nonoperating for fiscal 2023 was $1.25M.
| Period end | Interest Expense Nonoperating 12 month |
|---|---|
| 2025-12-31 | $33.00K 10-K · filed 2026-03-05 |
| 2024-12-31 | $14.00K 10-K · filed 2026-03-05 |
| 2023-12-31 | $1.25M 10-K · filed 2025-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |